BCL2 and breast carcinoma: Studies have found that microRNA-195 can target BCL-2 to trigger mitochondrial dysfunction and then cause apoptosis, thereby enhancing the therapeutic efficacy of the chemotherapy drug etoposide in breast cancer (39).